Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US90184D1000
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG006KDCHJ4
TWST
Twist Bioscience Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Diagnostics & Research · THEMEFOLIO: $HLTH
NAME
Twist Bioscience Corp
ISIN
US90184D1000
TICKER
TWST
MIC
XNAS
REUTERS
TWST.OQ
BLOOMBERG
TWST US
Mo., 30.01.2023       Twist Bioscience
US90184D1000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - January 29, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Sa., 28.01.2023       Twist Bioscience
US90184D1000

Radnor, Pennsylvania--(Newsfile Corp. - January 28, 2023) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019, an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Sa., 28.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 27, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the "Class Period"), of the important February 10, 2023 lead plaintiff deadline.S...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 26.01.2023       Twist Bioscience
US90184D1000

Radnor, Pennsylvania--(Newsfile Corp. - January 26, 2023) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019, an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 26.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 26, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 26.01.2023       Twist Bioscience
US90184D1000

Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. New York, New Yor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 26.01.2023       Twist Bioscience
US90184D1000

San Francisco, California--(Newsfile Corp. - January 25, 2023) - Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now. Class Period: Dec. 13, 2019 - Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit: www.hbsslaw.com/investor-fraud/TWST Contact An Attorney Now: TWS...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 25.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 25, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Twist an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 25.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 25, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Di., 24.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 24, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califo...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 23.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 23, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califo...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Sa., 21.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 20, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the "Class Period"), of the important February 10, 2023 lead plaintiff deadline.S...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Fr., 20.01.2023       Twist Bioscience
US90184D1000

Radnor, Pennsylvania--(Newsfile Corp. - January 20, 2023) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019, an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 19.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 19, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 19.01.2023       Twist Bioscience
US90184D1000

San Francisco, California--(Newsfile Corp. - January 19, 2023) - Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now.Class Period: Dec. 13, 2019 - Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit: www.hbsslaw.com/investor-fraud/TWSTContact An Attorney Now: TWST@...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 19.01.2023       Twist Bioscience
US90184D1000

Philadelphia, Pennsylvania--(Newsfile Corp. - January 19, 2023) - Securities fraud class action complaints allege that Twist Bioscience and certain of its officers overstated the commercial viability of Twist's synthetic DNA manufacturing technology while engaging in accounting fraud and using unrealistic pricing to give an artificially inflated vi...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 19.01.2023       Twist Bioscience
US90184D1000

Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.New York, New York--(Newsfile Corp. - January 19, 2023) - Bernstein Liebhard LLP, a nationally acclaimed inve...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 18.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 18, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Di., 17.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 17, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the "Class Period"), of the important February 10, 2023 lead plaintiff deadline.S...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Di., 17.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 17, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Twist an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 17.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 17, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mo., 16.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 16, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califo...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mo., 16.01.2023       Twist Bioscience
US90184D1000

Radnor, Pennsylvania--(Newsfile Corp. - January 16, 2023) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019, an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Sa., 14.01.2023       Twist Bioscience
US90184D1000

Radnor, Pennsylvania--(Newsfile Corp. - January 14, 2023) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019, an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Fr., 13.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 13, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Fr., 13.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 12, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the "Class Period"), of the important February 10, 2023 lead plaintiff deadline.S...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 12.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 12, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 12.01.2023       Twist Bioscience
US90184D1000

Boston, Massachusetts--(Newsfile Corp. - January 12, 2023) - Block & Leviton announces that a class action lawsuit has been filed against Twist Bioscience Corp. (NASDAQ: TWST) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those los...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 11.01.2023       Twist Bioscience
US90184D1000

Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. New York, New York--(N...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 11.01.2023       Twist Bioscience
US90184D1000

San Francisco, California--(Newsfile Corp. - January 11, 2023) - Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now.Class Period: Dec. 13, 2019 - Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit: www.hbsslaw.com/investor-fraud/TWST Contact An Attorney Now: TWST...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 11.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 11, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 11.01.2023       Twist Bioscience
US90184D1000

Radnor, Pennsylvania--(Newsfile Corp. - January 10, 2023) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation ("Twist") (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019, an...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Di., 10.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 10, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califo...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mo., 09.01.2023       Twist Bioscience
US90184D1000

Philadelphia, Pennsylvania--(Newsfile Corp. - January 9, 2023) - It is alleged that Twist Bioscience and certain of its officers overstated the commercial viability of the company's synthetic DNA manufacturing technology while engaging in accounting fraud and using unrealistic pricing to artificially inflate Twist Bioscience's true financial condit...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Sa., 07.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 7, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Twist and...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Sa., 07.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 7, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the "Class Period"), of the important February 10, 2023 lead plaintiff deadline.SO...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Fr., 06.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 6, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Californ...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 05.01.2023       Twist Bioscience
US90184D1000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - January 5, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience C...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Do., 05.01.2023       Twist Bioscience
US90184D1000

San Francisco, California--(Newsfile Corp. - January 5, 2023) - Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now.Class Period: Dec. 13, 2019 - Nov. 14, 2022Lead Plaintiff Deadline: Feb. 10, 2023Visit: www.hbsslaw.com/investor-fraud/TWST Contact An Attorney Now: TWST@...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 04.01.2023       Twist Bioscience
US90184D1000

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - January 4, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience C...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 04.01.2023       Twist Bioscience
US90184D1000

Did you lose money on investments in Twist Bioscience Corporation? If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights. New York, New Yor...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mi., 04.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 4, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Californ...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Di., 03.01.2023       Twist Bioscience
US90184D1000

Boston, Massachusetts--(Newsfile Corp. - January 3, 2023) - Block & Leviton announces that a class action lawsuit has been filed against Twist Bioscience Corp. (NASDAQ: TWST) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Di., 03.01.2023       Twist Bioscience
US90184D1000

Los Angeles, California--(Newsfile Corp. - January 3, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Twist Bioscience Corporation ("Twist" or "the Company") (NASDAQ: TWST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Di., 03.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 3, 2023) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company") of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District o...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Mo., 02.01.2023       Twist Bioscience
US90184D1000

Los Angeles, California--(Newsfile Corp. - January 2, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Twist Bioscience Corporation ("Twist" or "the Company") (NASDAQ: TWST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
So., 01.01.2023       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - January 1, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Twist Bioscience Corporation (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, both dates inclusive (the "Class Period"), of the important February 10, 2023 lead plaintiff deadli...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Sa., 31.12.2022       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - December 30, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Twist a...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Fr., 30.12.2022       Twist Bioscience
US90184D1000

New York, New York--(Newsfile Corp. - December 30, 2022) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit.The lawsuit on behalf of Twist investors has been commenced in the the United States District Court for the Northern District of Califo...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink
Fr., 30.12.2022       Twist Bioscience
US90184D1000

Los Angeles, California--(Newsfile Corp. - December 30, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Twist Bioscience Corporation ("Twist" or "the Company") (NASDAQ: TWST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 1...
Zur Nachricht
Twist Bioscience
Charts & Research Termsheets Terminal
Permalink